Diagnosis and management of adrenal cortical carcinoma

Current Urology Reports

Volumn 8, Issue 1, 2007, Pages 77-82

  Fulmer, Brant R ^a  

^a GEISINGER HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; METOMIDATE; METYRAPONE; MITOTANE; STREPTOZOCIN;

ADRENAL CORTEX CARCINOMA; ADVANCED CANCER; CANCER LOCALIZATION; CANCER STAGING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG CYTOTOXICITY; GASTROINTESTINAL SYMPTOM; HUMAN; LAPAROSCOPIC SURGERY; MORBIDITY; NEUROTOXICITY; RASH; REVIEW;

ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICAL CARCINOMA; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LAPAROSCOPY; MALE; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 33846834137     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-007-0024-6     Document Type: Review

References (50)

1. Allolio B, Hahner S, Weismann D, et al.: Management of adrenocortical carcinoma. Clin Endocrinol (Oxf) 2004, 60:273-287.
2. Liou LS, Kay R: Adrenocortical carcinoma in children. Review and recent innovations. Urol Clin North Am 2000, 27:403-421.
3. Bornstein SR, Stratakis CA, Chrousos GP: Adrenocortical tumors: recent advances in basic concepts and clinical management. Ann Intern Med 1999, 130:759-771.
4. Wajchenberg BL, Albergaria Pereira MA, Medonca BB, et al.: Adrenocortical carcinoma: clinical and laboratory observations. Cancer 2000, 88:711-736.
5. Lipsett MB: Treatment of adrenal carcinoma. Mod Treat 1966, 3:1377-1388.
6. Sidhu S, Gicquel C, Bambach CP, et al.: Clinical and molecular aspects of adrenocortical tumourigenesis. ANZ J Surg 2003, 73:727-738.
7. • Vaughan ED Jr: Diseases of the adrenal gland. Med Clin North Am 2004, 88:443-466. An excellent review article covering diagnosis and treatment of the wide scope of adrenal disease including an in-depth discussion of adrenocortical carcinoma.
8. Weiss LM: Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 1984, 8:163-169.
9. Wagner M, Walter PR, Ghnassia JP, et al.: [Adrenocortical tumors. I. Prognostic evaluation of a series of 17 cases using the Weiss criteria]. Ann Pathol 1993, 13:306-311.
10. Vassilopoulou-Sellin R, Schultz PN: Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer 2001, 92:1113-1121.
11. Fassnacht M, Kenn W, Allolio B: Adrenal tumors: how to establish malignancy? J Endocrinol Invest 2004, 27:387-399.
12. Sciarra F, Tosti-Croce C, Toscano V: Androgen-secreting adrenal tumors. Minerva Endocrinol 1995, 20:63-68.
13. Sweeney AT, Blake MA, Aish LS, et al.: A malignant aldosteronoma. Endocr Pract 2002, 8:373-377.
14. Daneman A, Chan HS, Martin J: Adrenal carcinoma and adenoma in children: a review of 17 patients. Pediatr Radiol 1983, 13:11-18.
15. Dunnick NR: Adrenal carcinoma. Radiol Clin North Am 1994, 32:99-108.
16. Dunnick NR, Korobkin M, Francis I: Adrenal radiology: distinguishing benign from malignant adrenal masses. AJR Am J Roentgenol 1996, 167:861-867.
17. Xiao XR, Ye LY, Shi LX, et al.: Diagnosis and treatment of adrenal tumours: a review of 35 years' experience. Br J Urol 1998, 82:199-205.
18. Schultz CL, Haaga JR, Fletcher BD, et al.: Magnetic resonance imaging of the adrenal glands: a comparison with computed tomography. AJR Am J Roentgenol 1984, 143:1235-1240.
19. Glazer GM: MR imaging of the liver, kidneys, and adrenal glands. Radiology 1988, 166:303-312.
20. Glazer GM, Francis IR, Quint LE: Imaging of the adrenal glands. Invest Radiol 1988, 23:3-11.
21. Hussain S, Belldegrun A, Seltzer SE, et al.: Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography. AJR Am J Roentgenol 1985, 144:61-65.
22. Belldegrun A, Hussain S, Seltzer SE, et al.: Incidentally discovered mass of the adrenal gland. Surg Gynecol Obstet 1986, 163:203-208.
23. Ng L, Libertino JM: Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 2003, 169:5-11.
24. Chang A, Glazer HS, Lee JK, et al.: Adrenal gland: MR imaging. Radiology 1987, 163:123-128.
25. Korobkin M, Lombardi TJ, Aisen AM, et al.: Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 1995, 197:411-418.
26. Roman S: Adrenocortical carcinoma. Curr Opin Oncol 2006, 18:36-42.
27. Kendrick ML, Lloyd R, Erickson L, et al.: Adrenocortical carcinoma: surgical progress or status quo? Arch Surg 2001, 136:543-549.
28. Boushey RP, Dackiw AP: Adrenal cortical carcinoma. Curr Treat Options Oncol 2001, 2:355-364.
29. •• Moinzadeh A, Gill IS: Laparoscopic radical adrenalectomy for malignancy in 31 patients. J Urol 2005, 173:519-252. Authors present a large laparoscopic series for the treatment of adrenal malignancy performed at a center of excellence for minimally invasive surgery.
30. Cobb WS, Kercher KW, Sing RF, et al.: Laparoscopic adrenalectomy for malignancy. Am J Surg 2005, 189:405-411.
31. • Sturgeon C, Kebebew E: Laparoscopic adrenalectomy for malignancy. Surg Clin North Am 2004, 84:755-774. Practical and in-depth review of laparoscopic treatment of adrenal malignancy with focus on port placement and technique.
32. Porpiglia F, Fiori C, Tarabuzzi R, et al.: Is laparoscopic adrenalectomy feasible for adrenocortical carcinoma or metastasis? BJU Int 2004, 94:1026.
33. Lombardi CP, Raffaelli M, Boscherini M, et al.: [Laparoscopic adrenalectomy in the treatment of malignant adrenal lesions]. Tumori 2003, 89:255-266.
34. O'Boyle CJ, Kapadia CR, Sedman PC, et al.: Laparoscopic transperitoneal adrenalectomy. Surg Endosc 2003, 17:1905-1909.
35. Nicolai N: Laparoscopic adrenalectomy. Tumori 2003, 89:556-559.
36. Suzuki H: Laparoscopic adrenalectomy for adrenal carcinoma and metastases. Curr Opin Urol 2006, 16:47-53.
37. Shen WT, Kebebew E, Clark OH, et al.: Reasons for conversion from laparoscopic to open or hand-assisted adrenalectomy: review of 261 laparoscopic adrenalectomies from 1993 to 2003. World J Surg 2004, 28:1176-1179.
38. Allolio B, Fassnacht M: Clinical review: Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006, 91:2027-2037.
39. Cohn K, Gottesman L, Brennan M: Adrenocortical carcinoma. Surgery 1986, 100:1170-1177.
40. Soffen EM, Solin LJ, Rubenstein JH, et al.: Palliative radiotherapy for symptomatic adrenal metastases. Cancer 1990, 65:1318-1320.
41. Bergenstal DMHR, Lipsett MB: Chemotherapy of Adrenocortical Cancer with o,p' DDD. Ann Internal Med 1960, 53:672.
42. Berruti A, Terzolo M, Pia A, et al.: Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer. Cancer 1998, 83:2194-2200.
43. Wooten MD, King DK: Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 1993, 72:3145-3155.
44. Hutter AM Jr, Kayhoe DE: Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients. Am J Med 1966, 41:581-592.
45. Lubitz JA, Freeman L, Okun R: Mitotane use in inoperable adrenal cortical carcinoma. JAMA 1973, 223:1109-1112.
46. Haak HR, Hermans J, van de Velde CJ, et al.: Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer 1994, 69:947-951.
47. Dogliotti L, Berruti A, Pia A, et al.: Cytotoxic chemotherapy for adrenocortical carcinoma. Minerva Endocrinol 1995, 20:105-109.
48. Ahlman H, Khorram-Manesh A, Jansson S, et al.: Cytotoxic treatment of adrenocortical carcinoma. World J Surg 2001, 25:927-933.
49. Eriksson B, Oberg K, Curstedt T, et al.: Treatment of hormone-producing adrenocortical cancer with o.p'DDD and streptozocin. Cancer 1987, 59:1398-1403.
50. •• Kirschner LS: Emerging treatment strategies for adrenocortical carcinoma: a new hope. J Clin Endocrinol Metab 2006, 91:14-21. An excellent review of potential chemotherapeutic strategies for adrenal cortical carcinoma. Additional focus on the pathobiology of adrenal disease and novel future directions for the treatment of adrenal malignancy.